Axonics Modulation Technologies Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Axonics Modulation prevailing Real Value cannot be determined due to lack of data. The current price of Axonics Modulation is $0.0. Our model approximates the value of Axonics Modulation from analyzing the firm fundamentals such as Current Valuation of 3.32 B, profit margin of (0.01) %, and Return On Equity of -0.0089 as well as examining its technical indicators and probability of bankruptcy.
Axonics Modulation Total Value Analysis
Axonics Modulation Technologies is presently estimated to have valuation of 3.32 B with market capitalization of 3.63 B, debt of 27.62 M, and cash on hands of 213.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Axonics Modulation fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.32 B | 3.63 B | 27.62 M | 213.23 M |
Axonics Modulation Investor Information
About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.1. Axonics Modulation had not issued any dividends in recent years. Based on the analysis of Axonics Modulation's profitability, liquidity, and operating efficiency, Axonics Modulation Technologies is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Axonics Modulation Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Axonics suggests not a very effective usage of assets in March.Axonics Modulation Ownership Allocation
Axonics Modulation holds a total of 51.11 Million outstanding shares. The majority of Axonics Modulation Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axonics Modulation to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axonics Modulation. Please pay attention to any change in the institutional holdings of Axonics Modulation Technologies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Axonics Modulation Profitability Analysis
The company reported the previous year's revenue of 366.38 M. Net Loss for the year was (6.09 M) with profit before overhead, payroll, taxes, and interest of 197.66 M.Axonics Modulation Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.1 M | |
| Quarterly Earnings Growth Y O Y | 8.448 | |
| Forward Price Earnings | 106.383 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world |